-
Combined analysis of the prevalence of drug-resistant hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE)Hermans, Lucas Etienne ...Background . European guidelines recommend treatment of chronic hepatitis B virus infection (CHB) with the nucleos(t)ide analogs (NAs) entecavir or tenofovir. However, many European CHB patients have ... been exposed to other NAs, which are associated with therapy failure and resistance. The CAPRE study was performed to gain insigh t in prevalence and characteristics of NA resistance in Europe. Methods . A survey was performed on genotypic resistance testing results acquired during routine monitoring of CHB patients with detectable serum hepatitis B virus DNA in European tertiary referral centers. Results . Data from 1568 patients were included. The majority (73.8%) were exposed to lamivudine monotherapy. Drug-resistant strains were detected in 52.7%. The most frequently encountered primary mutation was M204V/I (48.7%), followed by A181T/V (3.8%) and N236T (2.6%). In patients exposed to entecavir (n = 102), f ull resistance was present in 35.3%. Independent risk factors for resistance were age, viral load, and lamivudine exposure ( P < .001). Conclusions . These fi ndings support resistance testing in cases of apparent NA therapy failure. This survey highlights the impact of exposure to lamivudine and adefovir on development of drug resist ance and cross-resistance. Continued use of these NAs needs to be reconsidered at a pan-European level.Vir: The Journal of infectious diseases. - ISSN 0022-1899 (Vol. 213, no. 1, Jan. 2016, str. 39-48)Vrsta gradiva - članek, sestavni del ; neleposlovje za odrasleLeto - 2016Jezik - angleškiCOBISS.SI-ID - 33054937
Avtor
Hermans, Lucas Etienne |
Svicher, Valentina |
Diepstraten Pas, Suzan |
Salpin, Romina |
Alvarez, Marta |
Ben Ari, Ziv |
Boland, Greet |
Bruzzone, Bianca |
Lunar, Maja M., 1982- |
Poljak, Mario, 1965-
Teme
hepatitis B virus |
antiviral drug resistance |
genotypic resistance testing |
virus hepatitisa B |
protivirusna odpornost na zdravila |
testiranje genotipske odpornosti
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Hermans, Lucas Etienne | |
Svicher, Valentina | |
Diepstraten Pas, Suzan | |
Salpin, Romina | |
Alvarez, Marta | |
Ben Ari, Ziv | |
Boland, Greet | |
Bruzzone, Bianca | |
Lunar, Maja M., 1982- | 54554 |
Poljak, Mario, 1965- | 11622 |
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Obvestilo
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Mesto prevzema | Status gradiva | Rezervacija |
---|
Prosimo, počakajte trenutek.